Takeda allies with Frazier to spin out late-phase norovirus vaccine

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jul 30, 2021 at 11:12 AM.

  1. #1 cafead, Jul 30, 2021 at 11:12 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,033
    Likes Received:
    3
    via Takeda has spun out its norovirus vaccine prospect to create a biotech: HilleVax. Frazier Healthcare Partners has teamed up with Takeda to found HilleVax, providing investor support for a program that cleared phase 2b back in 2018.

    article source
     
    Quote

Reply to Thread